The global Oncology Radiopharmaceuticals Marketin Nuclear Medicine Market is estimated to be valued at US$ 6,700.5 million in 2020 and is expected to exhibit a CAGR of 8.0% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
Oncology Radiopharmaceuticals Marketin Nuclear Medicine are radioactive drugs used for diagnosis and treatment of various diseases such as cancer, cardiovascular disorders, and ... Read more
